Navigation Links
'Bacillus anthracis and Anthrax'
Date:1/12/2011

Few strands of bacteria have achieved such a central place in public consciousness as Bacillus anthracis, the bacteria which causes Anthrax. While today it is a feared weapon of bioterrorism Bacillus anthracis has played a significant historical role, especially through the research of the celebrated 19th century scientists Robert Koch and Louis Pasteur, in shaping our understanding of infectious diseases and immunology

In his new book Bacillus Anthracis and Anthrax Dr Nicholas Bergman brings both of these perspectives together to present a definitive 'state of the field' summary for anthrax research, providing a comprehensive guide to all aspects of the organism, ranging from basic biology to central public health issues.

"With all the attention and research that have been focused on Bacillus anthracis and anthrax in recent years, our understanding of both the organism and the disease has improved dramatically," said Bergman. "This book aims to provide a up-to-date reference that will be useful to scientists, medical and public health personnel, and those playing roles in shaping public policy."

Bacillus Anthracis and Anthrax covers all major aspects of Anthrax biology, from basic biology and pathogenesis to diagnosis, treatment, and prevention of anthrax bioterror-associated issues.

Throughout the book anthrax is considered historically as well biologically, with chapters ranging from the impact of anthrax on human history from 5000 BC by Peter Turnbull and Sean Shadomy, to an assessment of current anthrax vaccination research by Elke Saile and Conrad Quinn, as well as an analysis by Leonard Cole of anthrax as a weapon of war.

The biological analysis of B. anthracis, includes research on life cycle, differentiation, cellular structure, as well as the interaction of B. anthracis with the immune system.

Bacillus Anthracis and Anthrax also considers the clinical features, diagnosis and treatment of the different forms of human anthrax, as well as a review of animal models of anthrax and their use in research.

While Bacillus Anthracis and Anthrax will be a premier reference tool to B. Anthracis and anthrax for microbiologists, immunologists and physiologists it will also serve as an invaluable resource for medical professionals, bioterror experts and all those involved in the issues of public health.


'/>"/>

Contact: Ben Norman
Lifesciencenews@wiley.com
44-012-437-70375
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. Poll: Hypothetical anthrax attack and antibiotics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 22, 2017 , ... Donor ... and Nevada and LABS, Inc., announced the future opening of a CLIA certified ... and serology testing used to determine the suitability of potential organ and ...
(Date:3/22/2017)... (PRWEB) , ... March 22, 2017 , ... ... solution provider, today announced that its digital marketing solutions have enabled Children’s Hospital ... investment in 24 months. , Recognizing the value of a digital marketing ...
(Date:3/22/2017)... ... March 22, 2017 , ... Drs. Jennifer Houck, Lauren Smith, ... to accept new patients in need of skilled pediatric dentistry in Rock ... Care offers pediatric patients routine treatments, including cavities, sealants and fluoride applications, in a ...
(Date:3/22/2017)... Milford, PA (PRWEB) , ... March 22, 2017 , ... ... producers, according to a US Department of Agriculture report. While excess dairy can ... sensitivity play a role. Lactose sensitivity is the inability to properly digest lactose, a ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... financial consultations to families and business owners in the greater Hampton Roads area, ... American Cancer Society Relay For Life event. , Each year, hundreds of people ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... , 22. März 2017   ... und weltweit tätige Anbieter von Produkten und ... den Erwerb von EPL Archives Inc. bekannt, ... der Kunden im kompletten Zyklus regulierter Forschung, ... von Proben, Speicherung von Dokumenten und Zusatzdienstleistungen ...
(Date:3/22/2017)... 2017 TapImmune, Inc. (NASDAQ: ... development of innovative peptide and gene-based immunotherapeutics for ... announced that it will participate in two upcoming ... Glynn Wilson , Chairman and CEO of TapImmune, ... clinical pipeline and partnering opportunities for its proprietary ...
(Date:3/22/2017)... 22, 2017 A new independent study ... the proven ultraviolet-C (UV-C) disinfection solution of choice ... Published in the March issue ... , the peer-reviewed study of UV-C disinfection systems ... General Hospital and Rochester General Hospital. According to ...
Breaking Medicine Technology: